Safety, Tolerability, Pharmacokinetics and Anti-tumour Activity of Alflutinib in Advanced Non Small Cell Lung Cancer
Clinical trial NCT02973763 · TERMINATED
Trial details
- NCT number
- NCT02973763
- Sponsor
- Allist Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-30
- Primary completion
- 2021-02-04
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.